CB
RARE icon

Commerce Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History

Commerce Bank’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$403K Hold
12,058
– – ﹤0.01% 1046
2026
Q1 		$253K Buy
12,058
+2,953
+32% +$66.5K ﹤0.01% 1194
2025
Q4 		$209K Sell
9,105
-95
-1% -$3.12K ﹤0.01% 1192
2025
Q3 		$277K Buy
+9,200
New +$276K ﹤0.01% 1106
2022
Q2 		– Sell
-3,382
Closed -$246K – 1193
2022
Q1 		$246K Buy
+3,382
New +$235K ﹤0.01% 1070

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Commerce Bank's RARE Position: Q2 2026 in Review

Commerce Bank held its Ultragenyx Pharmaceutical (RARE) position steady in Q2 2026 at 12,058 shares worth $403K. The position accounts for ﹤0.01% of the portfolio, ranked #1046.

Commerce Bank first reported a position in RARE in Q1 2022 and has held it in 5 quarters since. 310 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Commerce Bank held 12,058 shares of Ultragenyx Pharmaceutical worth $403K as of Q2 2026.
  • Commerce Bank left its Ultragenyx Pharmaceutical share count unchanged in Q2 2026.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Commerce Bank's portfolio in Q2 2026, its #1046 holding.
  • Commerce Bank first reported a position in Ultragenyx Pharmaceutical in Q1 2022 and has held it in 5 quarters since.
  • 310 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.